Critical Review: Achieve Life Sciences (NASDAQ:ACHV) vs. Glass House Brands (OTCMKTS:GLASF)

Achieve Life Sciences (NASDAQ:ACHV) and Glass House Brands (OTCMKTS:GLASF) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Earnings & Valuation

This table compares Achieve Life Sciences and Glass House Brands”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Achieve Life Sciences	N/A	N/A	-$54.65 million	($1.55)	-5.38
Glass House Brands	N/A	N/A	N/A	N/A	N/A

Institutional & Insider Ownership

33.5% of Achieve Life Sciences shares are owned by institutional investors. 1.8% of Achieve Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Achieve Life Sciences and Glass House Brands’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Achieve Life Sciences	N/A	-511.12%	-82.35%
Glass House Brands	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings and target prices for Achieve Life Sciences and Glass House Brands, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Achieve Life Sciences	1	0	5	2	3.00
Glass House Brands	0	1	0	0	2.00

Achieve Life Sciences currently has a consensus target price of $15.00, suggesting a potential upside of 79.75%. Given Achieve Life Sciences’ stronger consensus rating and higher probable upside, analysts clearly believe Achieve Life Sciences is more favorable than Glass House Brands.

Summary

Achieve Life Sciences beats Glass House Brands on 6 of the 8 factors compared between the two stocks.

About Achieve Life Sciences

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.

About Glass House Brands

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. The company operates in three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods. It cultivates, manufactures, and distributes cannabis bulk flowers and trims to wholesalers; and consumer packaged goods to third-party retail stores in California. The company also owns and operates retail cannabis stores. In addition, it offers raw cannabis, cannabis oil, and cannabis consumer goods; edibles; flower jars and bags; single, multi-pack, and infused pre-rolls; tinctures; biomass for distributors; and online payment processing, in-store pickup and home delivery services for adult-use and medicinal-use customers. The company offers its cannabis products under the Glass House Farms, FIELD, Forbidden Flowers, PLUS, Mama Sue, Allswell, and REEFORM brand names. Glass House Brands Inc. was founded in 2015 and is headquartered in Long Beach, California.